Phthalazinone derivatives
US7750006B2 · kind B2 · utility
6Cited by
52References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 10, 2006 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Jan 16, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treatment of a disease of the human or animal body mediated by PARP comprising administering to such a subject a therapeutically effective amount of a compound of formula:or an isomer, salt, solvate, chemically protected form, and prodrug thereof, wherein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.